Clinical Trials · NCT07771283

Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage

Name: Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating Its Equivalence to Standard Controlled Ovarian Stimulation Protocols in Terms of Oocytes Retrieved, Blastulation While Maintaining an Economic Advantage
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Enrolling By InvitationN/AGonadorelin

Phase: N/A
Recruitment status: Enrolling By Invitation
Sponsor: LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro
Enrollment: 360
Start date: Aug 2026
Locations: 3 sites, Uganda, Ukraine
Primary endpoint: Number of oocytes retrieved (oocyte yield)

View Gonadorelin compound reference